Postoperative Troponin in Children With Congenital Heart Disease

NCT01616394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2014-11-19

No results posted yet for this study

Summary

The aim of the study is to evaluate the value of postoperative troponin in the prediction of mid term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.

Conditions

  • Congenital Heart Disease

Sponsors & Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Mona MOMENI, MD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Eligibility

Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01616394 on ClinicalTrials.gov